Theratechnologies (Canada)
Scientists at Theratechnologies discovered EGRIFTA® (tesamorelin for injection) in 1995. For the next fifteen years, Theratechnologies pursued the development of this innovative treatment for lipodystrophy in people living with HIV. In 2010, Theratechnologies received a marketing authorization for EGRIFTA® from the U.
Basic Information
- Category: business
- Website: https://www.theratech.com/
Documented Facts
- Email: privacy@theratech.com (No linked source recorded for this statement.)
- Founded: 1993 (No linked source recorded for this statement.)
- Employees: 100 (No linked source recorded for this statement.)
Evidence and Sources
- Theratechnologies (Canada) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Theratechnologies (Canada).
- Canonical profile: https://brandsource.ai/brands/theratechnologies-canada
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/theratechnologies-canada/json-ld
- Citation profile API: https://brandsource.ai/api/brands/theratechnologies-canada/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (83/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Scientists at Theratechnologies discovered EGRIFTA® (tesamorelin for injection) in 1995. For the next fifteen years, Theratechnologies pursued the development of this innovative treatment for lipodystrophy in people living with HIV. In 2010, Theratechnologies received a marketing authorization for EGRIFTA® from the U.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.